GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PharmaEngine 4162.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

52.20

-1.32%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 911.4m

FY2016FY2025

Net income

TWD 387.6m

FY2016FY2025

Free cash flow

TWD 1.73bn

FY2016FY2025

Shareholders' equity

TWD 4.93bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 911.4mTWD 2.52bnTWD 767.7mTWD 654.4mTWD 654.8mTWD 1.06bnTWD 314.0mTWD 293.4mTWD 853.7mTWD 1.13bn
Gross profitTWD 859.6mTWD 2.48bnTWD 719.0mTWD 604.7mTWD 617.8mTWD 1.02bnTWD 282.2mTWD 280.5mTWD 850.8mTWD 1.13bn
Research and developmentTWD 299.7mTWD 267.0mTWD 310.3mTWD 181.9mTWD 136.9mTWD 95.7mTWD 130.8mTWD 124.9mTWD 121.9mTWD 194.8m
Operating incomeTWD 425.5mTWD 2.05bnTWD 277.2mTWD 392.5mTWD 545.4mTWD 752.9mTWD 49.8mTWD 42.4mTWD 613.0mTWD 808.1m
Net incomeTWD 387.6mTWD 1.75bnTWD 274.6mTWD 318.8mTWD 426.0mTWD 604.3mTWD 42.5mTWD 129.4mTWD 387.1mTWD 689.6m
Diluted earnings per share2.7412.191.912.222.974.270.290.872.174.71

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 5.15bnTWD 5.85bnTWD 3.95bnTWD 3.97bnTWD 4.03bnTWD 4.21bnTWD 3.64bnTWD 3.85bnTWD 4.11bnTWD 3.96bn
Cash and short-term investments——TWD 3.63bnTWD 3.66bnTWD 3.81bnTWD 3.39bnTWD 3.42bnTWD 3.66bnTWD 3.28bnTWD 3.91bn
Total liabilitiesTWD 221.6mTWD 448.0mTWD 91.0mTWD 94.5mTWD 87.7mTWD 195.8mTWD 160.4mTWD 152.7mTWD 199.9mTWD 160.5m
Debt—TWD 7.1mTWD 14.8mTWD 22.3mTWD 7.6mTWD 22.1mTWD 32.9m———
Shareholders' equityTWD 4.93bnTWD 5.40bnTWD 3.86bnTWD 3.87bnTWD 3.94bnTWD 4.01bnTWD 3.48bnTWD 3.69bnTWD 3.91bnTWD 3.80bn
Shares outstanding142m144m144m144m143m141m148m148m178m146m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 1.73bnTWD 456.7mTWD 257.0mTWD 202.0mTWD 929.7mTWD 64.8mTWD 16.1mTWD 745.2m−TWD 339.3mTWD 870.4m
Capital spending−TWD 280,000−TWD 1.4m−TWD 958,000−TWD 3.9m−TWD 229,000−TWD 608,000−TWD 208,000−TWD 510,000−TWD 489,000−TWD 1.1m
Free cash flowTWD 1.73bnTWD 455.3mTWD 256.0mTWD 198.1mTWD 929.4mTWD 64.2mTWD 15.9mTWD 744.7m−TWD 339.8mTWD 869.2m
Dividends paid−TWD 861.9m−TWD 215.4m−TWD 287.2m−TWD 387.7m−TWD 364.0m−TWD 72.8m−TWD 145.7m−TWD 294.3m−TWD 245.2m−TWD 101.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 258.0mTWD 239.8mTWD 285.1mTWD 242.2mTWD 196.8mTWD 187.4mTWD 1.88bnTWD 218.2m
Gross profitTWD 239.1mTWD 224.6mTWD 269.1mTWD 229.5mTWD 186.0mTWD 175.0mTWD 1.87bnTWD 205.6m
Operating incomeTWD 116.5mTWD 129.9mTWD 119.0mTWD 119.8mTWD 97.9mTWD 88.8mTWD 1.73bnTWD 116.5m
Net incomeTWD 134.0mTWD 137.2mTWD 131.1mTWD 136.5mTWD 17.8mTWD 102.3mTWD 1.42bnTWD 92.2m
Diluted earnings per share0.930.960.910.950.120.719.870.64
Cash from operationsTWD 98.0mTWD 260.0mTWD 128.0mTWD 53.0m−TWD 263.0mTWD 1.81bnTWD 121.0mTWD 77.0m
Total assetsTWD 5.42bnTWD 5.28bnTWD 5.15bnTWD 4.91bnTWD 5.72bnTWD 5.95bnTWD 5.85bnTWD 4.06bn
Shareholders' equityTWD 4.91bnTWD 5.06bnTWD 4.93bnTWD 4.79bnTWD 4.66bnTWD 5.50bnTWD 5.40bnTWD 3.98bn

Financial ratios

Data as of 7 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin94.3%98.1%93.7%92.4%94.3%96.5%——
Operating margin55.9%85.7%36.1%60.0%83.3%71.3%——
Net margin42.5%69.4%35.8%48.7%65.1%57.2%——
Return on equity7.9%32.4%7.1%8.2%10.8%15.1%——
Return on assets7.5%29.9%6.9%8.0%10.6%14.4%——
Free cash flow yield—5.7%3.2%2.6%11.6%0.8%0.2%—
Revenue growth-63.9%228.7%17.3%-0.1%-38.0%236.3%——
Earnings growth-77.9%537.5%-13.8%-25.2%-29.5%1320.2%——
Current ratio27.17x13.15x46.78x49.86x45.71x22.61x——
Debt to equity——0.00x0.00x0.00x0.00x0.00x0.00x
Equity ratio95.7%92.3%97.7%97.6%97.8%95.3%——
Interest coverage3664.98x11951.25x894.14x5098.04x2572.60x1699.59x——
R&D as a share of sales32.9%10.6%40.4%27.8%20.9%9.1%——
Buybacks as a share of market value—-0.0%0.1%-0.2%-1.4%4.4%0.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.7%-2.9%6.0%
Operating income2.7%-10.8%2.7%
Net income6.7%-8.5%-0.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin97.1%95.9%95.9%96.6%
Operating margin72.2%64.8%67.7%65.0%
Net margin62.3%56.3%57.3%55.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings25.77.455.256.424.413.6238.2129.770.232.1
Price to sales10.95.119.727.415.97.832.357.231.819.5

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 17 Aug 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year2.006.001.502.002.70
  • 1199.953-for-1000 split · 26 Jul 2017
  • 1199.919-for-1000 split · 25 Jul 2016

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.